Your browser doesn't support javascript.
loading
Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy.
Bayda, Samer; Hadla, Mohamad; Palazzolo, Stefano; Kumar, Vinit; Caligiuri, Isabella; Ambrosi, Emmanuele; Pontoglio, Enrico; Agostini, Marco; Tuccinardi, Tiziano; Benedetti, Alvise; Riello, Pietro; Canzonieri, Vincenzo; Corona, Giuseppe; Toffoli, Giuseppe; Rizzolio, Flavio.
Afiliação
  • Bayda S; Department of Translational Research, National Cancer Institute - CRO-IRCCS, Aviano, Italy; Doctoral School in Nanotechnology, University of Trieste, Italy.
  • Hadla M; Department of Translational Research, National Cancer Institute - CRO-IRCCS, Aviano, Italy; Doctoral School in Pharmacological Sciences, University of Padova, Italy.
  • Palazzolo S; Department of Translational Research, National Cancer Institute - CRO-IRCCS, Aviano, Italy; Doctoral School in Nanotechnology, University of Trieste, Italy.
  • Kumar V; Department of Translational Research, National Cancer Institute - CRO-IRCCS, Aviano, Italy; Amity Institute of Molecular Medicine & Stem Cell Research, Amity University, Noida, India.
  • Caligiuri I; Department of Translational Research, National Cancer Institute - CRO-IRCCS, Aviano, Italy.
  • Ambrosi E; Department of Molecular Sciences and Nanosystems and Electron Microscopy Center "Giovanni Stevanato", University Ca' Foscari of Venezia, Italy; European Center of Living Technology, Venezia-Mestre, Italy.
  • Pontoglio E; Department of Molecular Sciences and Nanosystems and Electron Microscopy Center "Giovanni Stevanato", University Ca' Foscari of Venezia, Italy; European Center of Living Technology, Venezia-Mestre, Italy; Doctoral School in Chemistry, University of Trieste, Italy.
  • Agostini M; Department of Surgical, Oncological and Gastroenterological Sciences, Section of Surgery, University of Padova, Italy; Pediatric Research Institute, Città della Speranza, Padova, Italy.
  • Tuccinardi T; Department of Pharmacy, University of Pisa, Italy.
  • Benedetti A; Department of Molecular Sciences and Nanosystems and Electron Microscopy Center "Giovanni Stevanato", University Ca' Foscari of Venezia, Italy; European Center of Living Technology, Venezia-Mestre, Italy.
  • Riello P; Department of Molecular Sciences and Nanosystems and Electron Microscopy Center "Giovanni Stevanato", University Ca' Foscari of Venezia, Italy; European Center of Living Technology, Venezia-Mestre, Italy.
  • Canzonieri V; Department of Translational Research, National Cancer Institute - CRO-IRCCS, Aviano, Italy.
  • Corona G; Department of Translational Research, National Cancer Institute - CRO-IRCCS, Aviano, Italy.
  • Toffoli G; Department of Translational Research, National Cancer Institute - CRO-IRCCS, Aviano, Italy.
  • Rizzolio F; Department of Translational Research, National Cancer Institute - CRO-IRCCS, Aviano, Italy. Electronic address: frizzolio@cro.it.
J Control Release ; 248: 144-152, 2017 02 28.
Article em En | MEDLINE | ID: mdl-28093297
ABSTRACT
Nanomedicine requires intelligent and non-toxic nanomaterials for real clinical applications. Carbon materials possess interesting properties but with some limitations due to toxic effects. Interest in carbon nanoparticles (CNPs) is increasing because they are considered green materials with tunable optical properties, overcoming the problem of toxicity associated with quantum dots or nanocrystals, and can be utilized as smart drug delivery systems. Using black tea as a raw material, we synthesized CNPs with a narrow size distribution, tunable optical properties covering visible to deep red absorption, non-toxicity and easy synthesis for large-scale production. We utilized these CNPs to label subcellular structures such as exosomes. More importantly, these new CNPs can escape lysosomal sequestration and rapidly distribute themselves in the cytoplasm to release doxorubicin (doxo) with better efficacy than the free drug. The release of doxo from CNPs was optimal at low pH, similar to the tumour microenvironment. These CNPs were non-toxic in mice and reduced the tumour burden when loaded with doxo due to an improved pharmacokinetics profile. In summary, we created a new delivery system that is potentially useful for improving cancer treatments and opening a new window for tagging microvesicles utilized in liquid biopsies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbono / Portadores de Fármacos / Doxorrubicina / Nanopartículas / Antibióticos Antineoplásicos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbono / Portadores de Fármacos / Doxorrubicina / Nanopartículas / Antibióticos Antineoplásicos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article